LYZ and colorectal carcinoma: Similarly, patient stratification based on LYZ mRNA levels using the stage II Kemper CRC dataset [34] denoted a poor prognosis value of this marker (p = 0.30; HR = 3.35) (Figure 5B) that was not observed in the TCGA CRC dataset (Figure 5C).